Article
By the end of this year, more than 3 million LASIK procedures will have been performed in the United States. However, this number represents less than 1% of the people who are eligible for laser vision correction.
Opthea phase 3 clinical trial, COAST, in patients with wet age-related macular degeneration fails to meet primary endpoint
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Nicox announces last patient completed final visit in Whistler Phase 3b clinical trial
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Bausch + Lomb publishes results from phase 4 study evaluating patient-reported outcomes with Miebo in dry eye disease
Angiogenesis and the eye: A Journey to unlock the secrets of blood vessel growth